Jean Francois Formela - Net Worth and Insider Trading

Jean Francois Formela Net Worth

The estimated net worth of Jean Francois Formela is at least $494 Million dollars as of 2024-03-28. Jean Francois Formela is the Director, 10% Owner of Horizon Therapeutics PLC and owns about 3,688,294 shares of Horizon Therapeutics PLC (HZNP) stock worth over $429 Million. Jean Francois Formela is the Director of Intellia Therapeutics Inc and owns about 1,127,405 shares of Intellia Therapeutics Inc (NTLA) stock worth over $31 Million. Jean Francois Formela is also the Director of Exelixis Inc and owns about 584,519 shares of Exelixis Inc (EXEL) stock worth over $14 Million. Besides these, Jean Francois Formela also holds Ikena Oncology Inc (IKNA) , NxStage Medical Inc (NXTM) , Spero Therapeutics Inc (SPRO) , ARCA biopharma Inc (ABIO) , Translate Bio Inc (TBIO) . Details can be seen in Jean Francois Formela's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jean Francois Formela has not made any transactions after 2021-12-14 and currently still holds the listed stock(s).

Transaction Summary of Jean Francois Formela

To

Jean Francois Formela Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jean Francois Formela owns 11 companies in total, including Translate Bio Inc () , Intellia Therapeutics Inc () , and Spero Therapeutics Inc () among others .

Click here to see the complete history of Jean Francois Formela’s form 4 insider trades.

Insider Ownership Summary of Jean Francois Formela

Ticker Comapny Transaction Date Type of Owner
Translate Bio Inc 2021-09-14 director
Intellia Therapeutics Inc 2021-06-14 director
Spero Therapeutics Inc 2017-11-06 director
Egalet Corp 2014-02-11 director & 10 percent owner
ARCA biopharma Inc 2009-01-27 director
Horizon Therapeutics PLC 2012-03-02 director & 10 percent owner
Achillion Pharmaceuticals Inc 2007-12-14 director & 10 percent owner
NxStage Medical Inc 2006-05-26 director & 10 percent owner
Exelixis Inc 2005-09-07 director
Ikena Oncology Inc 2021-12-14 director
Korro Bio Inc 2023-11-03 director

Jean Francois Formela Latest Holdings Summary

Jean Francois Formela currently owns a total of 8 stocks. Among these stocks, Jean Francois Formela owns 3,688,294 shares of Horizon Therapeutics PLC (HZNP) as of March 2, 2012, with a value of $429 Million and a weighting of 86.82%. Jean Francois Formela owns 1,127,405 shares of Intellia Therapeutics Inc (NTLA) as of June 14, 2021, with a value of $31 Million and a weighting of 6.28%. Jean Francois Formela also owns 584,519 shares of Exelixis Inc (EXEL) as of September 7, 2005, with a value of $14 Million and a weighting of 2.81%. The other 5 stocks Ikena Oncology Inc (IKNA) , NxStage Medical Inc (NXTM) , Spero Therapeutics Inc (SPRO) , ARCA biopharma Inc (ABIO) , Translate Bio Inc (TBIO) have a combined weighting of 4.09% among all his current holdings.

Latest Holdings of Jean Francois Formela

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HZNP Horizon Therapeutics PLC 2012-03-02 3,688,294 116.30 428,948,592
NTLA Intellia Therapeutics Inc 2021-06-14 1,127,405 27.51 31,014,912
EXEL Exelixis Inc 2005-09-07 584,519 23.79 13,905,707
IKNA Ikena Oncology Inc 2021-12-14 5,018,178 1.42 7,100,722
NXTM NxStage Medical Inc 2005-10-27 218,944 30.00 6,568,320
SPRO Spero Therapeutics Inc 2017-11-06 3,785,096 1.73 6,548,216
ABIO ARCA biopharma Inc 2009-01-27 93 1.76 164
TBIO Translate Bio Inc 2021-09-14 0 37.36 0

Holding Weightings of Jean Francois Formela


Jean Francois Formela Form 4 Trading Tracker

According to the SEC Form 4 filings, Jean Francois Formela has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the acquisition of 828,443 shares on March 2, 2012, which cost Jean Francois Formela around $3 Million.

According to the SEC Form 4 filings, Jean Francois Formela has made a total of 4 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 201,725 shares on June 14, 2021, which brought Jean Francois Formela around $18 Million.

According to the SEC Form 4 filings, Jean Francois Formela has made a total of 0 transactions in Exelixis Inc (EXEL) over the past 5 years. The most-recent trade in Exelixis Inc is the sale of 275,000 shares on September 7, 2005, which brought Jean Francois Formela around $2 Million.

More details on Jean Francois Formela's insider transactions can be found in the Insider Trading History of Jean Francois Formela table.

Insider Trading History of Jean Francois Formela

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jean Francois Formela Trading Performance

GuruFocus tracks the stock performance after each of Jean Francois Formela's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jean Francois Formela is -7.53%. GuruFocus also compares Jean Francois Formela's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jean Francois Formela within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jean Francois Formela's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jean Francois Formela

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 3.57 -7.53 -15.04 -46.04 -2.79 -1.27
Relative Return to S&P 500(%) 1.19 -10.23 -21.26 -57.86 -14.31 -9.5

Jean Francois Formela Ownership Network

Ownership Network List of Jean Francois Formela

No Data

Ownership Network Relation of Jean Francois Formela


Jean Francois Formela Owned Company Details

What does Translate Bio Inc do?

Who are the key executives at Translate Bio Inc?

Jean Francois Formela is the director of Translate Bio Inc. Other key executives at Translate Bio Inc include director & Chief Executive Officer & other: President Renaud Ronald C Jr , Chief Operating Officer & CLO & other: Secretary Paul D. Burgess , and 10 percent owner Shire Human Genetic Therapies, Inc. .

Translate Bio Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Translate Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Translate Bio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Translate Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Translate Bio Inc Insider Transactions

No Available Data

Jean Francois Formela Mailing Address

Above is the net worth, insider trading, and ownership report for Jean Francois Formela. You might contact Jean Francois Formela via mailing address: C/o Atlas Venture, 890 Winter Street, Waltham Ma 02451.

Discussions on Jean Francois Formela

No discussions yet.